- Home
- JGH vs TCMD Comparison
JGH vs TCMD Comparison
Compare JGH & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JGH
- TCMD
- Stock Information
- Founded
- JGH 2014
- TCMD 1995
- Country
- JGH United States
- TCMD United States
- Employees
- JGH N/A
- TCMD N/A
- Industry
- JGH Investment Managers
- TCMD Medical/Dental Instruments
- Sector
- JGH Finance
- TCMD Health Care
- Exchange
- JGH Nasdaq
- TCMD Nasdaq
- Market Cap
- JGH 306.4M
- TCMD 300.1M
- IPO Year
- JGH N/A
- TCMD 2016
- Fundamental
- Price
- JGH $13.43
- TCMD $14.81
- Analyst Decision
- JGH
- TCMD Buy
- Analyst Count
- JGH 0
- TCMD 4
- Target Price
- JGH N/A
- TCMD $16.83
- AVG Volume (30 Days)
- JGH 73.9K
- TCMD 183.7K
- Earning Date
- JGH 01-01-0001
- TCMD 11-03-2025
- Dividend Yield
- JGH 9.85%
- TCMD N/A
- EPS Growth
- JGH N/A
- TCMD N/A
- EPS
- JGH N/A
- TCMD 0.63
- Revenue
- JGH N/A
- TCMD $298,851,000.00
- Revenue This Year
- JGH N/A
- TCMD $8.78
- Revenue Next Year
- JGH N/A
- TCMD $8.49
- P/E Ratio
- JGH N/A
- TCMD $23.64
- Revenue Growth
- JGH N/A
- TCMD 6.15
- 52 Week Low
- JGH $10.36
- TCMD $8.61
- 52 Week High
- JGH $12.85
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- JGH 44.41
- TCMD 66.57
- Support Level
- JGH $13.34
- TCMD $14.74
- Resistance Level
- JGH $13.70
- TCMD $15.48
- Average True Range (ATR)
- JGH 0.11
- TCMD 0.36
- MACD
- JGH -0.01
- TCMD 0.05
- Stochastic Oscillator
- JGH 16.67
- TCMD 70.41
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of current income. Its securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.